|
104
|
269
|
2npaA |
The crystal structure of the human pparaplpha ligand binding domain in complex with a a-hydroxyimino phenylpropanoic acid |
|
93
|
238
|
2lbdA |
Ligand-binding domain of the human retinoic acid receptor gamma bound to all-trans retinoic acid |
|
88
|
238
|
2nv7A |
Crystal structure of estrogen receptor beta complexed with way-555 |
|
94
|
248
|
2nw4A |
Crystal structure of the rat androgen receptor ligand binding domain complex with bms-564929 |
|
85
|
225
|
2jfaA |
Estrogen receptor alpha lbd in complex with an affinity-selected corepressor peptide |
|
83
|
224
|
2jf9A |
Estrogen receptor alpha lbd in complex with a tamoxifen-specific peptide antagonist |
|
85
|
223
|
2jfaB |
Estrogen receptor alpha lbd in complex with an affinity-selected corepressor peptide |
|
88
|
237
|
2j7xA |
Structure of estradiol-bound estrogen receptor beta lbd in complex with lxxll motif from ncoa5 |
|
84
|
238
|
2jj3A |
Estrogen receptor beta ligand binding domain in complex with a benzopyran agonist |
|
70
|
239
|
2iokA |
Human estrogen receptor alpha ligand-binding domain in complex with compound 1d |
|
86
|
243
|
2iogA |
Human estrogen receptor alpha ligand-binding domain in complex with compound 11f |
|
99
|
266
|
2j14A |
3,4,5-trisubstituted isoxazoles as novel ppardelta agonists: part2 |
|
88
|
237
|
2j7yA |
Structure of 17-epiestriol-bound estrogen receptor beta lbd in complex with lxxll motif from ncoa5 |
|
93
|
250
|
2j4aA |
Human thyroid hormone receptor beta ligand binding domain in complex with kb131084 |
|
94
|
270
|
2i4jA |
Crystal structure of the complex between ppargamma and the agonist lt160 (ureidofibrate derivative) |
|
93
|
248
|
2ihqA |
Crystal structure of the rat androgen receptor ligand binding domian complex with an n-aryl-hydroxybicyclohydantoin |
|
98
|
250
|
2hvcA |
The crystal structure of ligand-binding domain (lbd) of human androgen receptor in complex with a selective modulator lgd2226 |
|
99
|
270
|
2i4pA |
Crystal structure of the complex between ppargamma and the partial agonist lt127 (ureidofibrate derivative). structure obtained from crystals of the apo-form soaked for 30 days. |
|
99
|
270
|
2i4zA |
Crystal structure of the complex between ppargamma and the partial agonist lt127 (ureidofibrate derivative). this structure has been obtained from crystals soaked for 6 hours. |
|
104
|
254
|
2harA |
Crystal structure of vdr lbd in complex with 2 alpha-(3-hydroxy-1-propoxy) calcitriol |
|
97
|
271
|
2hwqA |
Structural basis for the structure-activity relationships of peroxisome proliferator-activated receptor agonists |
|
95
|
299
|
2hc4A |
Crystal structure of the lbd of vdr of danio rerio in complex with calcitriol |
|
81
|
223
|
2i0jA |
Benzopyrans are selective estrogen receptor beta agonists (serbas) with novel activity in models of benign prostatic hyperplasia |
|
103
|
272
|
2hfpA |
Crystal structure of ppar gamma with n-sulfonyl-2-indole carboxamide ligands |
|
96
|
271
|
2hwrA |
Structural basis for the structure-activity relationships of peroxisome proliferator-activated receptor agonists |
|
82
|
238
|
2i0gA |
Benzopyrans are selective estrogen receptor beta agonists (serbas) with novel activity in models of benign prostatic hyperplasia |
|
102
|
254
|
2hasA |
Crystal structure of vdr lbd in complex with 2alpha-(1-propoxy) calcitriol |
|
93
|
265
|
2gwxA |
Molecular recognition of fatty acids by peroxisome proliferator-activated receptors |
|
99
|
267
|
2h79A |
Crystal structure of human tr alpha bound t3 in orthorhombic space group |
|
88
|
224
|
2gpvA |
Estrogen related receptor-gamma ligand binding domain complexed with 4-hydroxy-tamoxifen and a smrt peptide |
|
101
|
254
|
2hb7A |
Crystal structure of vdr lbd in complex with 2alpha(3-hydroxy-1-propyl) calcitriol |
|
101
|
271
|
2gtkA |
Structure-based design of indole propionic acids as novel pparag co-agonists |
|
102
|
299
|
2hbhA |
Crystal structure of vitamin d nuclear receptor ligand binding domain bound to a locked side-chain analog of calcitriol and src-1 peptide |
|
90
|
255
|
2h77A |
Crystal structure of human tr alpha bound t3 in monoclinic space group |
|
98
|
254
|
2hb8A |
Crystal structure of vdr lbd in complex with 2alpha-methyl calcitriol |
|
103
|
254
|
2hamA |
Crystal structure of vdr lbd complexed to 2alpha-propyl-calcitriol |
|
85
|
224
|
2gp7A |
Estrogen related receptor-gamma ligand binding domain |
|
88
|
299
|
2hcdA |
Crystal structure of the ligand binding domain of the vitamin d nuclear receptor in complex with gemini and a coactivator peptide |
|
87
|
222
|
2gpuA |
Estrogen related receptor-gamma ligand binding domain complexed with 4-hydroxy-tamoxifen |
|
88
|
224
|
2gpoA |
Estrogen related receptor-gamma ligand binding domain complexed with a synthetic peptide from rip140 |
|
84
|
225
|
2gppA |
Estrogen related receptor-gamma ligand binding domain complexed with a rip140 peptide and synthetic ligand gsk4716 |
|
80
|
241
|
2giuA |
Human estrogen receptor beta ligand-binding domain in complex with compound 45 |
|
80
|
245
|
2g5oA |
Human estrogen receptor alpha ligand-binding domain in complex with 2-(but-1-enyl)-17beta-estradiol and a glucocorticoid receptor interacting protein 1 nr box ii peptide |
|
64
|
214
|
2gl8A |
Human retinoic acid receptor rxr-gamma ligand-binding domain |
|
96
|
271
|
2g0hA |
Structure-based drug design of a novel family of ppar partial agonists: virtual screening, x-ray crystallography and in vitro/in vivo biological activities |
|
83
|
244
|
2g44A |
Human estrogen receptor alpha ligand-binding domain in complex with obcp-1m-g and a glucocorticoid receptor interacting protein 1 nr box ii peptide |
|
80
|
238
|
2fszA |
A second binding site for hydroxytamoxifen within the coactivator-binding groove of estrogen receptor beta |
|
101
|
271
|
2g0gA |
Structure-based drug design of a novel family of ppar partial agonists: virtual screening, x-ray crystallography and in vitro/in vivo biological activities |
|
100
|
271
|
2fvjA |
A novel anti-adipogenic partial agonist of peroxisome proliferator-activated receptor-gamma (pparg) recruits pparg-coactivator-1 alpha (pgc1a) but potentiates insulin signaling in vitro |
|
85
|
224
|
2ewpA |
Crystal structure of estrogen related receptor-3 (err-gamma) ligand binding domaind with tamoxifen analog gsk5182 |
